Outcomes of simultaneous liver and kidney transplantation in relation to a high level of preformed donor-specific antibodies

Transplantation

Volumn 96, Issue 10, 2013, Pages 914-918

  Leca, Nicolae ^a   Warner, Paul ^a   Bakthavatsalam, Ramaswamy ^a   Nelson, Karen ^a   Halldorson, Jeffrey ^a   Rayhill, Stephen ^a   Kendrick, Elizabeth ^a   Davis, Connie ^a   Reyes, Jorge ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Combined liver kidney transplantation; Donor specific antibodies; Rejection

Indexed keywords

CD4 ANTIGEN; CREATININE; HLA ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN; RITUXIMAB;

ADULT; ANTIBODY SPECIFICITY; ANTIBODY TITER; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; FEMALE; HLA MATCHING; HLA SENSITIZATION; HLA SYSTEM; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SENSITIZATION; SIMULTANEOUS LIVER AND KIDNEY TRANSPLANTATION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ANTIBODIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; SURVIVAL RATE; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; UNITED STATES;

EID: 84891832532     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182a192f5     Document Type: Review

References (12)

1. Davis CL, Feng S, Sung R, et al. Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant 2007; 7: 1702.
2. Chopra A, Cantarovich M, Bain VG. Simultaneous liver and kidney transplants: optimizing use of this double resource. Transplantation 2011; 91: 1305.
3. Mehta SD, Leehey DJ. Disparity in utilization of combined kidneyliver transplantation in the United States. Clin Transplant 2009; 23: 938.
4. Pham PT, Pham PC, Wilkinson AH. Renal function outcomes following liver transplantation and combined liver-kidney transplantation. Nat Clin Pract Nephrol 2007; 3: 507.
5. Rana A, Robles S, Russo MJ, et al. The combined organ effect: protection against rejection? Ann Surg 2008; 248: 871.
6. Davis CL, Gonwa TA, Wilkinson AH. Identification of patients best suited for combined liver-kidney transplantation: part II. Liver Transpl 2002; 8: 193.
7. Shapiro R, Zeevi A. Why does combined liver and kidney transplantation confer an immunologic benefit to a kidney? Pediatr Transplant 2010; 14: 439.
8. Mosconi G, Scolari MP, Feliciangeli G, et al. Combined liver-kidney transplantation with preformed anti-HLA antibodies: a case report. Transplant Proc 2006; 38: 1125.
9. Askar M, Schold JD, Eghtesad B, et al. Combined liver-kidney transplants: allosensitization and recipient outcomes. Transplantation 2011; 91: 1286.
10. Barth RN, Campos L, Kukuruga DL, et al. Antibody-mediated rejection of renal allograft in combined liver-kidney transplant. Clin Transplant 2010; 24: 685.
11. Reichman TW, Marino SR, Milner J, et al. Acute humoral rejection in an ABO compatible combined liver-kidney transplantYthe kidney is not always protected. Am J Transplant 2009; 9: 1957.
12. Dar W, Agarwal A, Watkins C, et al. Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants. Am J Transplant 2011; 11: 841.